Population Pharmacokinetics Modeling and Simulation of Deutenzalutamide, A Novel Androgen Receptor Antagonist, in Patients With Metastatic Castration‐Resistant Prostate Cancer

Documenti analoghi

• Population Pharmacokinetics and Exposure‐Response Relationship of Zimberelimab in Chinese Patients with Advanced Tumors
  di: Fang Yang, et al.
  Pubblicazione: (2024)
• Pharmacokinetics, Tolerability, and Biomarker Profile of the Neurokinin 3 Receptor Antagonist Fezolinetant in Healthy Japanese Individuals: A 2‐Part, Randomized, Phase 1 Study
  di: Akira Koibuchi, et al.
  Pubblicazione: (2025)
• Population Pharmacokinetics of Butylphthalide Injection in Elderly Chinese Patients With Ischemic Stroke
  di: Shu‐Xian Lyu, et al.
  Pubblicazione: (2025)
• Pharmacokinetics, Receptor Occupancy, and Pharmacodynamics of Obexelimab Following Intravenous Administration in Adult Healthy Volunteers and in Patients With Rheumatoid Arthritis
  di: Xiaodong Wang, et al.
  Pubblicazione: (2025)
• Population Pharmacokinetics of Fasinumab in Healthy Volunteers and Patients With Pain Due to Osteoarthritis of the Knee or Hip
  di: Kuan‐Ju Lin, et al.
  Pubblicazione: (2024)